GlycoMimetics, Inc. (GLYC) Reaches $20.25 High on Jan, 14; Last Week Nighthawk Energy plc (LON:HAWK) Coverage

January 14, 2018 - By Michael Collier

Among 2 analysts covering Nighthawk Energy PLC (LON:HAWK), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nighthawk Energy PLC had 3 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Tuesday, May 30 by Stockdale Securities. On Wednesday, July 29 the stock rating was maintained by Westhouse Securities with “Buy”. Westhouse Securities maintained it with “Buy” rating and GBX 12.50 target in Wednesday, October 28 report. See Nighthawk Energy plc (LON:HAWK) latest ratings:

The stock of GlycoMimetics, Inc. (NASDAQ:GLYC) reached all time high today, Jan, 14 and still has $21.26 target or 5.00% above today’s $20.25 share price. This indicates more upside for the $695.34M company. This technical setup was reported by Barchart.com. If the $21.26 PT is reached, the company will be worth $34.77 million more. The stock decreased 2.69% or $0.56 during the last trading session, reaching $20.25. About 424,952 shares traded. GlycoMimetics, Inc. (NASDAQ:GLYC) has risen 81.25% since January 14, 2017 and is uptrending. It has outperformed by 64.55% the S&P500.

The stock decreased 13.04% or GBX 0.07 during the last trading session, reaching GBX 0.5. About 2.82M shares traded. Nighthawk Energy plc (LON:HAWK) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Nighthawk Energy Plc, an independent oil and natural gas company, engages in the exploration, development, production, and sale of hydrocarbons in the United States. The company has market cap of 4.82 million GBP. The Company’s primary assets are the Jolly Ranch and Smoky Hill project covering an area of approximately 300,000 gross acres located in the state of Colorado, the United States. It currently has negative earnings.

Analysts await GlycoMimetics, Inc. (NASDAQ:GLYC) to report earnings on March, 7. They expect $-0.26 EPS, up 27.78% or $0.10 from last year’s $-0.36 per share. After $-0.24 actual EPS reported by GlycoMimetics, Inc. for the previous quarter, Wall Street now forecasts 8.33% negative EPS growth.

Among 5 analysts covering GlycoMimetics (NASDAQ:GLYC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. GlycoMimetics had 15 analyst reports since August 10, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Tuesday, December 12 report. The rating was maintained by Cowen & Co on Tuesday, June 6 with “Buy”. The firm has “Buy” rating by Jefferies given on Tuesday, December 19. On Monday, August 10 the stock rating was upgraded by Zacks to “Hold”. The firm earned “Buy” rating on Friday, July 7 by Jefferies. The firm has “Buy” rating given on Tuesday, July 26 by SunTrust. The firm has “Buy” rating by Jefferies given on Tuesday, September 12. Jefferies maintained GlycoMimetics, Inc. (NASDAQ:GLYC) on Monday, June 5 with “Buy” rating. The firm earned “Buy” rating on Thursday, August 3 by Stifel Nicolaus. The firm has “Outperform” rating given on Monday, August 15 by Cowen & Co.

Since September 18, 2017, it had 0 insider buys, and 2 sales for $56,020 activity. 2,000 shares were sold by Thackray Helen M., worth $26,000 on Monday, September 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>